Minerva Neurosciences reported $1.2M in Trade Creditors for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 7.72M 1.34M
Adma Biologics ADMA:US $ 17.28M 11.12M
Arena Pharmaceuticals ARNA:US $ 6.94M 3.15M
Bristol Myers Squibb BMY:US $ 2695M 914M
Dynavax Technologies DVAX:US $ 3.6M 8.48M
Eli Lilly And LLY:US $ 1566.8M 31M
Esperion Therapeutics ESPR:US $ 20.74M 8.61M
Halozyme Therapeutics HALO:US $ 3.32M 1.24M
Kindred Biosciences KIN:US 926K 573K
Marinus Pharmaceuticals MRNS:US $ 0.69M 2.62M
Minerva Neurosciences NERV:US $ 1.2M 0.39M
Novartis NOVN:VX 4.66B 146M
Novavax NVAX:US $ 59.56M 14.43M
Takeda 4502:JP Y 336600M 15955M